Next, we selected PLC/PRF/5 cells (high NEDD4 expression) and HepG2.215 cells (low NEDD4 expression) to investigate the regulatory effect of NEDD4 in HBV-associated HCC. This evidence concerns the gene NEDD4 and hepatocellular carcinoma.